Work

No benefit from daratumumab, bortezomib and dexamethasone (D‐Vd) in real‐world patients with functional high‐risk multiple myeloma: A report from the Myeloma and Related Diseases Registry

Year: 2025

Type: article

Study design: Observational Study

Source: British Journal of Haematology

DOI: 10.1111/bjh.70238

Authors: Sueh‐li Lim, Cameron Wellard, Rajeev Rajagopal, Simon J. Harrison, Amit Khot, Hang Quach, Phoebe J. Ho, Elizabeth Moore, Erica Wood, Andrew Spencer

Institutions: The Alfred Hospital, Alfred Health, Monash University, Middlemore Hospital, The Royal Melbourne Hospital, The University of Melbourne, Peter MacCallum Cancer Centre, St Vincent's Hospital Melbourne, The University of Sydney, Royal Prince Alfred Hospital

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Johnson and Johnson

OpenAlex ID: W4416039361

FWCI: 0.635

Cites: 5

Cited by: 1

Related to: